Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6574)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kwon D, Yun JY, Keam B, Kim YT, Jeon YK. Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma. World J Gastroenterol 2016; 22(44): 9803-9812 [PMID: 27956804 DOI: 10.3748/wjg.v22.i44.9803] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i44/9803.htm |
| Number | Citing Articles |
| 1 |
Baoqing Chen, Shurui Liu, Lu Gan, Jingwen Wang, Binbin Hu, He Xu, Ruizhan Tong, Hui Yang, Ivan Cristina, Jianxin Xue, Xun Hu, You Lu. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients. Cancer Biology & Therapy 2018; 19(1): 76 doi: 10.1080/15384047.2017.1394541
|
| 2 |
Hui Shi, Yinting Mao, Qianqian Ju, Yingcheng Wu, Wen Bai, Peiwen Wang, Yudong Zhang, Maorong Jiang. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4367
|
| 3 |
Yu Lian, Xiangdong Niu, Hui Cai, Xiaojun Yang, Haizhong Ma, Shixun Ma, Yupeng Zhang, Yifeng Chen. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma. Tumor Biology 2017; 39(7): 101042831771580 doi: 10.1177/1010428317715804
|
| 4 |
Zhongwei Xin, Xuemin Song, Bin Jiang, Xin Gongsun, Liang Song, Qiming Qin, Qiang Wang, Mo Shi, Xiangyan Liu. Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma. Thoracic Cancer 2018; 9(12): 1687 doi: 10.1111/1759-7714.12883
|
| 5 |
Nanchang Yin, Wei Liu. <p>Clinical Value of Tumor Marker Index Based on Preoperative CYFRA 21-1 and SCC-Ag in the Evaluation of Prognosis and Treatment Effectiveness in Patients with Esophageal Squamous Cell Carcinoma</p>. OncoTargets and Therapy 2020; : 4135 doi: 10.2147/OTT.S243038
|
| 6 |
Sivesh K Kamarajah, Ella J Marson, Dengyi Zhou, Freddie Wyn-Griffiths, Aaron Lin, Richard P T Evans, James R Bundred, Pritam Singh, Ewen A Griffiths. Meta-analysis of prognostic factors of overall survival in patients undergoing oesophagectomy for oesophageal cancer. Diseases of the Esophagus 2020; 33(11) doi: 10.1093/dote/doaa038
|
| 7 |
Lemeng Zhang, Jianhua Chen, Tianli Cheng, Hua Yang, Changqie Pan, Haitao Li. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1980921
|
| 8 |
Dong Wang, Licheng Du, Zhou Wang, Xiangyan Liu, Yejun Qin, Qiangxiu Wang, Zhe Yang, Zhigang Yao, Mo Shi, Bin Shang, Yang Jia, Huaxia Chen, Liang Qiao, Xueqing Wang, Zhaohua Xiao, Zhenchuan Liu. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma. Oncotarget 2017; 8(51): 88857 doi: 10.18632/oncotarget.21486
|
| 9 |
Jie Huang, Dongxian Jiang, Ting Zhu, Yanqiu Wang, Hao Wang, Qun Wang, Lijie Tan, Hongguang Zhu, Junxia Yao, Yingyong Hou. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery 2019; 107(2): 436 doi: 10.1016/j.athoracsur.2018.07.077
|